LSL Pharma Group Inc (TSE:LSL) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
LSL Pharma Group Inc. reported impressive financial results for Q3-24, with revenues up 60% and a significant reduction in net losses by 84% compared to the previous year. The company also raised $2.4 million through debt financings to bolster its growth initiatives, including doubling production capacity at Steri-Med Pharma.
For further insights into TSE:LSL stock, check out TipRanks’ Stock Analysis page.